How to Help Your Patients Save Money on Nextstellis 28 Day: A Provider's Guide to Savings Programs

Nextstellis 28 Day carries a retail price of $240–$300 per pack without insurance. For patients with inadequate coverage or high deductibles, the cost can be a real barrier to continuity of care. As a prescriber, understanding the available savings pathways is essential to getting your patients on — and keeping them on — Nextstellis.

This guide summarizes every cost-reduction resource available in 2026, with practical steps for incorporating savings discussions into your prescribing workflow.

Understanding the Cost Landscape for Nextstellis

Nextstellis is a brand-only drug with no FDA-approved generic. This places it in a challenging position on insurance formularies — often at Tier 3 or higher on commercial plans, requiring either higher cost-sharing or prior authorization. Key financial facts:

• Retail cash price: $240–$303 per 28-tablet pack
• With GoodRx coupon: ~$65 per pack
• With Mayne Pharma savings card (insured with coverage): As little as $0/month
• With Mayne Pharma savings card (uninsured or uncovered): As little as $25/month or $50 per 3-month supply (~$17/month)
• Medicare Part D: Generally does not cover Nextstellis

Resource 1: Mayne Pharma Nextstellis Copay Savings Card

The Nextstellis Copay Savings Card from Mayne Pharma is the most powerful cost-reduction tool available for most patients. Printable from nextstellis.com/savings, it works as follows:

• Commercially insured patients with formulary coverage: As little as $0 per 1- or 3-month prescription fill.
• Commercially insured patients without Nextstellis coverage / cash-pay patients: As little as $25 per 1-month supply or $50 per 3-month supply (less than $17/month).

Important eligibility exclusions: Not available to patients with Medicaid, Medicare, TRICARE, or other government-funded insurance. Eligibility restrictions apply — review terms at nextstellis.com/savings.

Clinical practice recommendation: Print the savings card (or include the URL) on every Nextstellis prescription handout. Proactive provision at the point of prescribing significantly increases adherence and reduces prescription abandonment.

Resource 2: Prior Authorization — Make It Work for Your Patients

When insurers deny or require PA for Nextstellis, a well-documented PA request can unlock formulary coverage at the patient's regular copay — sometimes as low as $0 under ACA contraceptive mandates. Key elements of a successful PA letter:

• Document the patient's history with EE-based pills — side effects experienced (e.g., libido decrease, mood changes, bloating, elevated SHBG concerns, acne)
• Explain the clinical rationale for estetrol: tissue-selective estrogen with lower SHBG impact and more neutral lipid/liver effects compared to EE comparators
• Highlight drospirenone's anti-androgenic benefit for patients with acne or androgen-related concerns
• Reference Phase 3 clinical data (published in Contraception journal, 2021) showing Nextstellis's safety and tolerability profile

Consider developing a standard PA template for your practice to reduce administrative time per request.

Resource 3: Recommend a 90-Day Supply

Writing a 90-day supply prescription can reduce cost in two ways:

1. Many insurance plans offer lower per-month copays for 90-day fills, especially through mail-order pharmacy benefits.
2. The Mayne Pharma savings card offers $50 for a 3-month supply compared to $25 per individual monthly fill — saving $25 over three months.

Direct patients toward their insurance plan's mail-order pharmacy benefit when prescribing 90-day supplies, as this often provides the most favorable pricing.

Resource 4: GoodRx and Prescription Discount Cards for Uninsured Patients

For patients who are uninsured and not eligible for the Mayne Pharma savings card, GoodRx provides coupons that reduce the cash price to approximately $65 per 28-tablet pack at major chain pharmacies — about 75% off retail. Other discount cards (SingleCare, RxGo) offer varying prices; recommend patients compare prices at their preferred pharmacy before filling.

Resource 5: Patient Assistance Programs for Low-Income Patients

For patients who are uninsured and cannot afford the medication even with coupons, contact Mayne Pharma directly at 1-844-825-8500 or through nextstellis.com to inquire about patient assistance programs (PAPs). PAPs typically provide medications at no cost or significantly reduced cost to qualifying low-income patients without insurance coverage.

Resource 6: When Cost Is an Absolute Barrier — Therapeutic Alternatives

If all savings options are exhausted and cost remains prohibitive, consider therapeutic alternatives that share Nextstellis's progestin:

• Generic drospirenone/EE 0.02 mg (generic Yaz): Same progestin as Nextstellis; widely available generically at $15–$30/month with most insurance plans. Appropriate when EE tolerance is not a clinical concern.
• Generic norgestimate/EE (generic Ortho Tri-Cyclen): Lowest-cost generics; Tier 1 on most formularies. Appropriate when anti-androgenic and anti-mineralocorticoid effects are not the primary clinical priority.

Provider Quick Reference: Nextstellis Cost-Reduction Checklist

• ☐ Provide Mayne Pharma savings card URL at time of prescribing (nextstellis.com/savings)
• ☐ Run insurance benefits check — verify formulary tier and PA requirements
• ☐ Submit PA proactively with documented clinical rationale if required
• ☐ Prescribe 90-day supply to maximize mail-order or savings card value
• ☐ Recommend GoodRx (~$65/pack) for uninsured patients ineligible for savings card
• ☐ Contact Mayne Pharma PAP for qualifying low-income uninsured patients
• ☐ Consider generic drospirenone/EE as cost-effective alternative when clinically appropriate

The Bottom Line

The combination of the Mayne Pharma savings card, proactive prior authorization, and 90-day mail-order prescribing can eliminate or dramatically reduce the financial barrier to Nextstellis for most commercially insured patients. For access challenges beyond cost, see our companion article on how to help patients find Nextstellis in stock. And medfinder for providers is available as a resource when your patients can't find Nextstellis at local pharmacies.